| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $12.89 ▼ -0.97% | Yesterday | $13.07 ▲ +0.41% | Tomorrow's Amneal Pharmaceuticals Inc. Class A Common Stock (AMRX) setup is anchored to $13.02 and targets $12.89 (-0.97%). The near-term read is downside; watch $13.41 / $12.63 because daily realized volatility is about 5.01%. |
Tomorrow's Amneal Pharmaceuticals Inc. Class A Common Stock (AMRX) setup is anchored to $13.02 and targets $12.89 (-0.97%). The near-term read is downside; watch $13.41 / $12.63 because daily realized volatility is about 5.01%. | ||||
| Week | $12.63 ▼ -3.02% | Last Week | $13.19 ▲ +1.27% | The 7-day Amneal Pharmaceuticals Inc. Class A Common Stock model moves from $13.19 to $12.63 (-3.02%). It gives downside momentum context for this stock, so breaks around $13.41 / $12.63 matter more than a single tick. |
The 7-day Amneal Pharmaceuticals Inc. Class A Common Stock model moves from $13.19 to $12.63 (-3.02%). It gives downside momentum context for this stock, so breaks around $13.41 / $12.63 matter more than a single tick. | ||||
| Month | $12.18 ▼ -6.44% | Last Month | $13.37 ▲ +2.71% | The 1-month Amneal Pharmaceuticals Inc. Class A Common Stock target is $12.18 (-6.44%), compared with the live reference near $13.02. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Amneal Pharmaceuticals Inc. Class A Common Stock target is $12.18 (-6.44%), compared with the live reference near $13.02. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $11.51 ▼ -11.57% | Last Year | $13.65 ▲ +4.86% | The 1-year Amneal Pharmaceuticals Inc. Class A Common Stock scenario points to $11.51 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Amneal Pharmaceuticals Inc. Class A Common Stock scenario points to $11.51 (-11.57%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $9.95 ▼ -23.57% | 5 Years Ago | $14.31 ▲ +9.90% | The 5-year Amneal Pharmaceuticals Inc. Class A Common Stock view is $9.95 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Amneal Pharmaceuticals Inc. Class A Common Stock view is $9.95 (-23.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $13.02 | Mid |
| Daily Change | -1.81% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 61% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $13.02 | Daily Change | -1.81% |
| Market Cap | $4.15B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.